SYNER-G BIOPHARMA GROUP

Live / Registered — Registered (as of 28 May 2024)

What this means for you

Registered since 28 May 2024. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
97030469
Registration number
7402522
Mark type
Design + words
Filed
16 Sept 2021
Published for opposition
08 Aug 2023
Registered
28 May 2024
Attorney of record
Sara M. Bauer

Goods and services

  • Class 035 — Advertising and business services: Providing business intelligence services in the fields of pharmaceuticals, biotechnology, and life sciences; business consulting services in the fields of pharmaceuticals and biopharmaceuticals and related technologies, specifically, business consulting with respect to clinical development, formulation, evaluation, approval, delivery, commercialization, marketing, and life-cycle management of drugs; business services, namely, formulation of best practices for drug discovery, formulation development, clinical supplies, pharmacology, toxicology, clinical supplies, and clinical development services; regulatory submission management, namely, assisting others in preparing and filing applications for new pharmaceuticals with governmental regulatory bodies
  • Class 042 — Scientific and technological services: Consulting services in the fields of pharmaceutical research and development, biotechnology, and life sciences; providing scientific research services in the fields of pharmaceutical design and development, pharmaceutical chemistry, pharmaceutical manufacturing and controls; consulting services regarding research and development, pharmaceutical drug formulation development, and quality control for others in the fields of pharmaceuticals, biotechnology, and life sciences; technical advisory services in the fields of pharmaceutical research and development, biotechnology, and life sciences; technical consulting in the fields of pharmaceutical research and development, biotechnology, and life sciences; technical consulting services, namely, evaluating the safety of pharmaceutical products in clinical development or in commercial production; consultation services relating to consumer software in the fields of pharmaceuticals, biotechnology, and life sciences; Consulting services for others in the field of design, planning, and implementation project management of clinical trial development and clinical trials; Providing technical consulting services in the nature of advising on the testing, analysis and evaluation of the goods of others to determine conformity with certification standards; design and development of computer software for database management in the fields of pharmaceuticals, biotechnology and life sciences; pharmaceutical drug development services; toxicology services; Scientific research consulting in the field of clinical trial development and clinical trials
  • Class 045 — Legal and security services: Regulatory compliance consulting in the fields of pharmaceuticals, biotechnology, and life sciences

Owner

Prosecution history

  • 28 May 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
  • 28 May 2024 — REGISTERED-PRINCIPAL REGISTER
  • 24 Apr 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
  • 24 Apr 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
  • 20 Apr 2024 — STATEMENT OF USE PROCESSING COMPLETE
  • 02 Apr 2024 — USE AMENDMENT FILED
  • 20 Apr 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
  • 02 Apr 2024 — TEAS STATEMENT OF USE RECEIVED
  • 26 Oct 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
  • 26 Oct 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
  • 26 Oct 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
  • 26 Oct 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
  • 26 Oct 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
  • 03 Oct 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
  • 08 Aug 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

View this trademark record on Marksy